Luna Innovations Achieves 26% Revenue Growth for the Second Quarter
2006 ROANOKE, Va., Aug. 10 /PRNewswire-FirstCall/ -- Luna
Innovations Incorporated (NASDAQ:LUNA) today announced its
financial results for the quarter ended June 30, 2006. (Logo:
http://www.newscom.com/cgi-bin/prnh/20060627/LUNALOGO ) Revenues
for the 2006 second quarter increased 26% to $4.9 million, from
$3.9 million for the same quarter of 2005, reflecting growth in
contract research revenues of approximately $0.3 million and
product and license revenues of approximately $0.8 million. Gross
profit increased to $1.4 million, or 29% of revenues, in the second
quarter of 2006, from $1.1 million, or 28% of revenues, in the
second quarter of 2005. Operating expense increased to $4.3 million
in the second quarter of 2006, from $1.0 million in the second
quarter of 2005. The increase in year over year operating expense
reflects the company's strategy, begun in late 2005, to increase
its product portfolio and product sales, which included the
acquisition of Luna Technologies in September 2005, and hiring of
twelve additional employees focused specifically on new product
development, including nanotechnology and ultrasound-related
product candidates. Operating expenses in the second quarter of
2006 also include an additional $0.4 million in share-based
compensation expense, as well as administrative costs associated
with the company's growing employee base and its transformation to
a public company. Fifteen employees have also been added since the
comparable prior year period in administrative positions including
management, contracts, facilities, finance, and sales. As a result
of these increases in operating expenses, the company incurred a
loss from operations of $2.8 million in the second quarter of 2006,
versus an income of $0.1 million for the prior year's comparable
quarter. The net loss applicable to common stockholders for the
second quarter of 2006 was $2.7 million, or $0.37 per share on a
diluted basis, compared to a net income applicable to common
stockholders of $0.04 million or $0.01 per share, for the second
quarter of the previous year. Kent Murphy, Chairman, President and
Chief Executive Officer, commented, "Our contract backlog remains
strong and continues to grow. In addition to achieving a growth
rate of 7% in contract research revenues for the second quarter of
2006, our contract research backlog has grown over 24% from the
same period in 2005. As a result of this increased backlog, we have
stepped- up our efforts to recruit the highly trained and skilled
technical and professional individuals that we need to continue our
contract revenue growth for the remainder of 2006." Murphy
continued, "We remain excited about our investments in our products
pipeline. These include products such as the Emboli Detection and
Classification ("EDAC") blood circuit monitor, which we launched in
the second quarter of 2006, the development of the next generation
Distributed Sensing System, and other products with long term
opportunity to support our growth." Business Highlights * Raised
$17.7 million in net proceeds from the company's June 2, 2006,
initial public offering. These proceeds will allow the company to
accelerate its process of researching and developing technologies
in funding alliances with valued partners and then seeking to
commercialize the most promising technologies. * Significantly
improved the number of active Small Business Innovation Research
(SBIR) Phase II contracts. At the end of June 30, 2006, Luna
Innovations had 28 active SBIR Phase II contracts, compared to 17
in same period of 2005, marking a 65% percent increase. * Launched
the company's EDAC(TM) blood circuit monitor product in May 2006
and have since started receiving orders for products. Employing
missile tracking algorithms originally developed for the defense
industry, the system is designed to provide cardiothoracic
surgeons, perfusionists and anesthesiologists with a means of
accurately counting and classifying emboli in the blood stream. *
Announced the appointment of Dale Messick to the role of Chief
Financial Officer, and the appointment of Scott Graeff, Luna
Innovations' former CFO, to the role of Chief Commercialization
Officer. Graeff will lead the company's product commercialization
and business development efforts, while Messick will focus on the
company's financial administration. * Hired 38 new employees in the
second quarter of 2006, including new sales team members, and
materials science, optics, and life sciences professionals. This
brings the total number of new hires to date in 2006 to 65, which
includes 54 full-time and 11 part-time employees. Financial
Highlights * Revenues for the second quarter of 2006 increased 26%
compared to the second quarter of 2005 and 9% compared to the first
quarter of 2006. * Product revenues represented over 15% of total
revenues in the second quarter of 2006, versus 0% in the second
quarter of 2005, and 13% in the first quarter of 2006. Product
revenues grew to approximately $0.8 million in the second quarter
of 2006, versus $0.6 million in the first quarter of 2006. * Gross
profit for the second quarter of 2006 increased to $1.4 million, or
29% of revenues, from $1.1 million, or 28% of revenues, for the
corresponding period of 2005. * The company reported a loss per
share for the second quarter of 2006 of $0.37 per share, on a
diluted basis, compared to earnings per share of $0.01 for the
second quarter of 2005. * Cash and cash equivalents totaled $26.7
million at June 30, 2006, compared to $12.5 million at December 31,
2005. Conference Call Information As previously announced, Luna
Innovations will conduct an investor conference call at 5:30 p.m.
(EDT) today to discuss the company's second quarter 2006 financial
results. The call can be accessed by dialing (866) 713-8395
domestically or (617) 597-5309 internationally prior to the start
of the call. The access code is 70216945. The conference call will
also be webcast live over the Internet. The webcast can be accessed
by logging on to the "Investor Relations" section of the Luna
Innovations' website, http://www.lunainnovations.com/, prior to the
event. The webcast will be archived under the "Webcasts and
Presentations" section of the Luna Innovations website for at least
30 days following the conference call. About Luna Innovations Luna
Innovations (NASDAQ:LUNA) researches, develops and commercializes
innovative technologies in molecular technology and sensing
solutions. Luna accelerates the process of bringing new and
innovative products to market by focusing on technologies that can
fulfill identified market needs and then takes these technologies
from the applied research stage through commercialization. Since
its inception, Luna has successfully developed products for the
energy, telecommunications, life sciences and defense industries.
Headquartered in Roanoke, Virginia, the company has research,
development and manufacturing facilities in Blacksburg,
Charlottesville, Hampton, and Danville, Virginia, and a sales
office in McLean, Virginia. Additional information can be found at
the company's website, http://www.lunainnovations.com/. FORWARD
LOOKING STATEMENTS This press release includes information that
constitutes "forward-looking statements" made pursuant to the safe
harbor provision of the Private Securities Litigation Reform Act of
1995, including but not limited to (i) our contract backlog remains
strong and continues to grow, (ii) our product pipeline includes
products with long-term opportunity to support our growth, and
(iii) proceeds from the company's initial public offering will
allow the company to accelerate its process of researching and
developing technologies. The company has attempted, whenever
possible, to identify these forward- looking statements by words
such as "intends," "will," "plans," "anticipates," "expects,"
"may," "estimates," "believes," "should," "projects," or
"continue," or the negative of those words and other comparable
words. Similarly, statements that describe the company's business
strategy, goals, prospects, opportunities, outlook, objectives,
plans or intentions are also forward-looking statements. Luna
Innovations wishes to take advantage of the "safe harbor" provided
by the Private Securities Litigation Reform Act of 1995 and you are
cautioned that actual events or results may differ materially from
the expectations expressed in such forward-looking statements as a
result of various factors, including risks and uncertainties, many
of which are beyond Luna Innovations' control. Luna Innovations
cannot guarantee future results, levels of activity, performance,
or achievements. Factors that could cause actual results to differ
materially from the expectations expressed in such forward-looking
statements include, but are not limited to: (1) we may be unable to
manage our growth effectively, (2) we may experience continuing
losses, (3) we may not be successful in identifying market needs
for new products, (4) we will continue to rely on contract
research, including government grants and contracts available only
to small businesses, for a significant portion of our revenue, (5)
we may become ineligible for small business government grants and
contracts in the future, (6) we face substantial competition in our
markets, (7) our proprietary rights may be insufficient to protect
our technologies, (8) third parties may claim that we infringe
their intellectual property rights, (9) as a provider of contract
research for the U.S. government, we may be subject to federal
audits and investigations, (10) our ability to develop and market
certain of our products may be delayed by U.S. Food and Drug
Administration or other regulatory requirements, (11) we may
continue to face difficulty in, or increased costs related to,
hiring, training and retaining skilled employees, (12) we have
limited manufacturing experience and may experience unanticipated
manufacturing or supply problems, (13) changes in customer demand
for our products and product candidates, (14) the impact of a
slowdown in the overall economy, and (15) the uncertainty of the
current global political environment and the potential for
terrorist attacks. Additional factors that may affect the future
results of Luna Innovations are set forth in its Registration
Statement on Form S-1, its quarterly report on Form 10-Q and other
filings with the Securities and Exchange Commission ("SEC"), which
are available at the SEC's website at http://www.sec.gov/, and at
Luna Innovations' website at http://www.lunainnovations.com/. These
risk factors are updated from time to time through the filing of
periodic reports and registration statements with the SEC. The
statements made in this press release are based on information
available to the company as of the date of this release and Luna
Innovations undertakes no obligation to update any of the
forward-looking statements herein after the date of this press
release. Luna Innovations Incorporated Consolidated Statements of
Operations Three Months Ended Six Months Ended June 30, June 30,
2006 2005 2006 2005 (unaudited) (unaudited) Revenues: Contract
research revenues $ 4,170,273 $3,913,145 $ 8,091,212 $7,169,526
Product and license revenues 762,442 - 1,357,740 - Total revenues
4,932,715 3,913,145 9,448,952 7,169,526 Cost of revenues: Contract
research costs 3,105,289 2,800,075 6,013,124 5,471,195 Product and
license costs 408,219 - 674,270 - Total cost of revenues 3,513,508
2,800,075 6,687,394 5,471,195 Gross Profit 1,419,207 1,113,070
2,761,558 1,698,331 Operating expense 4,252,343 1,030,904 7,694,351
1,912,431 Operating income (loss) (2,833,136) 82,166 (4,932,793)
(214,100) Other income (expense) Other income (expense) 3,110 177
9,397 690 Interest income / (expense), net 109,185 (25,545) 113,145
(65,313) Total other income (expense) 112,295 (25,368) 122,542
(64,623) Income (loss) before income taxes (2,720,841) 56,798
(4,810,251) (278,723) Income tax expense (benefit) - 12,406 -
(60,877) Net income (loss) $(2,720,841) $ 44,392 $(4,810,251) $
(217,846) Net income (loss) per share: Basic $ (0.37) $ 0.02 $
(0.72) $ (0.07) Diluted $ (0.37) $ 0.01 $ (0.72) $ (0.07) Weighted
average shares: Basic 7,277,964 2,911,255 6,677,306 2,911,255
Diluted 7,277,964 4,928,242 6,677,306 2,911,255 Luna Innovations
Incorporated Consolidated Balance Sheets June 30, December 31, 2006
2005 Assets (unaudited) Current assets Cash and cash equivalents $
26,676,477 $ 12,514,839 Accounts receivable, net 4,148,196
5,129,911 Refundable income taxes 396,062 514,797 Inventory 669,219
448,475 Other current assets 474,827 227,409 Total current assets
32,364,781 18,835,431 Property and equipment, net 3,287,947
2,972,287 Intangible assets, net 1,429,443 999,544 Deferred
offering costs - 710,018 Deferred tax asset 600,000 600,000 Other
assets 14,482 16,550 Total assets $ 37,696,653 $ 24,133,830
Liabilities and stockholders' equity Current liabilities Current
portion of capital lease obligation $95,307 $98,820 Current portion
of long-term debt obligation 214,955 - Accounts payable 2,316,327
3,647,505 Accrued liabilities 3,113,197 1,788,162 Deferred credits
968,517 1,458,393 Total current liabilities 6,708,303 6,992,880
Long-term capital lease obligation 70,748 117,134 Long-term debt
obligation 5,000,000 5,214,955 Deferred credits 450,000 450,000
Total liabilities 12,229,051 12,774,969 Redeemable Class B common
stock, 308,216 shares at December 31, 2005 - 504,984 Stockholders'
equity: Common stock; 49,785,326 shares authorized for the
following classes: Common stock, par value $0.001; 9,829,038 shares
issued and outstanding at June 30, 2006 9,829 - Class A voting
common stock, par value $0.001; 2,834,814 issued and outstanding at
December 31, 2005 - 2,835 Class B non-voting common stock, par
value $0.001; 734,427 shares issued and outstanding at December 31,
2005 - 734 Class C voting common stock, par value $0.001; 2,131,474
issued and outstanding at December 31, 2005 - 2,131 Additional
paid-in capital 30,350,713 10,935,049 Accumulated deficit
(4,892,940) (86,872) Total stockholders' equity 25,467,602
10,853,877 Total liabilities and stockholders' equity $ 37,696,653
$ 24,133,830 Luna Innovations Incorporated Consolidated Statements
of Cash Flows Six Months Ended June 30, 2006 2005 (unaudited) Cash
flows from (used in) operating activities Net loss $ (4,810,251) $
(217,846) Adjustments to reconcile net loss to net cash provided by
operating activities: Depreciation and amortization 502,401 179,187
Deferred income taxes - (30,106) Share-based compensation 761,282
98,101 Change in assets and liabilities: Accounts receivable
981,715 (252,668) Refundable income taxes 118,735 731,234 Other
assets (466,093) (81,079) Accounts payable and accrued expenses
703,875 (203,378) Deferred revenues (489,876) (31,296) Net cash
from (used in) operating activities (2,698,212) 192,149 Cash flows
used in investing activities Acquisition of property and equipment
(632,587) (389,047) Intangible property costs (197,300) (156,185)
Capitalized software development costs - (14,468) Net cash used in
investing activities (829,887) (559,700) Cash flows from (used in)
financing activities Net payments on line of credit - (170,000)
Payments on capital lease obligations (49,899) (12,956) Proceeds
from the issuance of common stock, net 17,660,608 - Proceeds from
the exercise of options and warrants 79,028 - Net cash from (used
in) financing activities 17,689,737 (182,956) Net change in cash
14,161,638 (550,507) Cash -- beginning of period 12,514,839 609,636
Cash -- end of period $ 26,676,477 $ 59,129 Supplemental disclosure
of cash flow information Cash paid for interest $ 22,717 $ 47,727
Cash paid for income taxes $ - $ - Property and equipment financed
by capital leases $ - $ 11,700
http://www.newscom.com/cgi-bin/prnh/20060627/LUNALOGO
http://photoarchive.ap.org/ DATASOURCE: Luna Innovations
Incorporated CONTACT: Media: Mildred Cooper of Luna Innovations,
+1-540-557-7561, ; or Investors: Sally Beerbower of Qorvis
Communications, +1-703-744-7800, , for Luna Innovations
Incorporated Web site: http://www.lunainnovations.com/
Copyright
Luna Innovations (NASDAQ:LUNA)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Luna Innovations (NASDAQ:LUNA)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024